Hong Kong
· Delayed Price · Currency is HKD CANbridge Pharmaceuticals Statistics
Total Valuation
HKG:1228 has a market cap or net worth of HKD 57.74 million. The enterprise value is 191.05 million.
| Market Cap | 57.74M |
| Enterprise Value | 191.05M |
Important Dates
The last earnings date was Thursday, May 29, 2025.
| Earnings Date | May 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1228 has 424.56 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 424.56M |
| Shares Outstanding | 424.56M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 10.03% |
| Owned by Institutions (%) | 14.89% |
| Float | 310.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| PB Ratio | -0.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.41 |
| EV / Sales | 2.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.47 |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.11 |
| Interest Coverage | -39.67 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -83.11% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 93.09% |
| Revenue Per Employee | 1.35M |
| Profits Per Employee | -7.03M |
| Employee Count | 67 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 3.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.50% in the last 52 weeks. The beta is -0.36, so HKG:1228's price volatility has been lower than the market average.
| Beta (5Y) | -0.36 |
| 52-Week Price Change | -57.50% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.19 |
| Relative Strength Index (RSI) | 47.37 |
| Average Volume (20 Days) | 2,628,250 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1228 had revenue of HKD 90.56 million and -471.02 million in losses. Loss per share was -1.11.
| Revenue | 90.56M |
| Gross Profit | 57.79M |
| Operating Income | -362.37M |
| Pretax Income | -471.02M |
| Net Income | -471.02M |
| EBITDA | -347.77M |
| EBIT | -362.37M |
| Loss Per Share | -1.11 |
Balance Sheet
The company has 11.18 million in cash and 144.49 million in debt, giving a net cash position of -133.31 million or -0.31 per share.
| Cash & Cash Equivalents | 11.18M |
| Total Debt | 144.49M |
| Net Cash | -133.31M |
| Net Cash Per Share | -0.31 |
| Equity (Book Value) | -504.94M |
| Book Value Per Share | -1.19 |
| Working Capital | -465.32M |
Cash Flow
In the last 12 months, operating cash flow was -130.25 million and capital expenditures -111,738, giving a free cash flow of -130.36 million.
| Operating Cash Flow | -130.25M |
| Capital Expenditures | -111,738 |
| Free Cash Flow | -130.36M |
| FCF Per Share | -0.31 |
Margins
| Gross Margin | 63.81% |
| Operating Margin | -400.12% |
| Pretax Margin | -520.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:1228 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | n/a |
| Earnings Yield | -815.76% |
| FCF Yield | -225.77% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:1228 has an Altman Z-Score of -63.7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -63.7 |
| Piotroski F-Score | n/a |